GSK : CDC's Panel Votes To Recommend Arexvy For Prevention Of RSV Disease In Older Adults
22/6 03:00
(RTTNews) - GSK plc (GSK,GSK.L) said that the US Centers for Disease Control and Prevention's or CDC Advisory Committee on Immunization Practices or ACIP voted in favor of recommending the use of Arexvy (respiratory syncytial virus vaccine, adjuvanted) in adults aged 60 and older...